Arbele announces early safety data for novel CDH17xCD3 bispecific T-cell engager at American Society of Clinical Oncology Breakthrough Meeting ...Middle East

SYDNEY, Aug. 2, 2023 /PRNewswire/ -- Arbele, a clinical-stage biotechnology company developing novel immunotherapies targeted for advanced gastrointestinal cancers, presented early safety data from its first-in-class CDH17xCD3 bispecific T-cell engager antibody, ARB202, at the ASCO...

Hence then, the article about arbele announces early safety data for novel cdh17xcd3 bispecific t cell engager at american society of clinical oncology breakthrough meeting was published today ( Thursday 03/08/2023 - 02:09 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Arbele announces early safety data for novel CDH17xCD3 bispecific T-cell engager at American Society of Clinical Oncology Breakthrough Meeting )

Also on site :

• Several Denver-area gas stations pumped contaminated fuel this week, King Soopers warns
• Man police shot in Brooklyn hospital was former NYPD officer, police said
• Parker Waichman LLP Files Lawsuit on behalf of Chicago Resident in the Paragard MDL Alleging Injuries Caused by Breakage of the Copper IUD